000 01249 a2200313 4500
005 20250516025655.0
264 0 _c20110516
008 201105s 0 0 eng d
022 _a1091-6490
024 7 _a10.1073/pnas.1019656108
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHormigo, Adília
245 0 0 _aA target for antiangiogenic therapy: vascular endothelium derived from glioblastoma.
_h[electronic resource]
260 _bProceedings of the National Academy of Sciences of the United States of America
_cMar 2011
300 _a4271-2 p.
_bdigital
500 _aPublication Type: Comment; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngiogenesis Inhibitors
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aCell Transdifferentiation
_xdrug effects
650 0 4 _aEndothelial Cells
_xmetabolism
650 0 4 _aGlioblastoma
_xblood supply
650 0 4 _aHumans
650 0 4 _aMice
700 1 _aDing, Bi-Sen
700 1 _aRafii, Shahin
773 0 _tProceedings of the National Academy of Sciences of the United States of America
_gvol. 108
_gno. 11
_gp. 4271-2
856 4 0 _uhttps://doi.org/10.1073/pnas.1019656108
_zAvailable from publisher's website
999 _c20655719
_d20655719